Ex vivo ras peptide vaccination in patients with advanced pancreatic cancer: results of a phase I/II study.
Gjertsen MK, Bakka A, Breivik J, Saeterdal I, Gedde-Dahl T 3rd, Stokke KT, Sølheim BG, Egge TS, Søreide O, Thorsby E, Gaudernack G.
Gjertsen MK, et al. Among authors: soreide o.
Int J Cancer. 1996 Feb 8;65(4):450-3. doi: 10.1002/(SICI)1097-0215(19960208)65:4<450::AID-IJC10>3.0.CO;2-E.
Int J Cancer. 1996.
PMID: 8621226
Clinical Trial.